Promega Madison Achieves ISO 14001 Certification for Environmental Management
ISO 14001 is an internationally recognized standard for environmental management systems.Certification recognizes the biotechnology manufacturer’s ongoing commitment to environmental stewardship and sustainability.Promega announces certification in 2025 Corporate Responsibility Report released today
Promega Corporation announced today that its headquarters in Madison, Wisconsin has achieved ISO 14001:2015 certification, an internationally recognized standard for environmental management systems. This certification reflects the biotechnology manufacturer’s longstanding commitment to environmental stewardship and sustainability.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505641030/en/
Promega Madison has achieved ISO 14001:2015 certification for its environmental management system. Promega announced the certification in its annual Corporate Responsibility Report, which also features sustainability metrics and details on how the biotechnology manufacturer supports scientists, employees and communities.
“For more than 45 years, Promega has been dedicated to environmental management and sustainable practices within the life sciences industry,” says Jaime Dwight, Director, Environmental Health & Safety and Controlled Substances. “This certification embodies the effort we have invested in fostering a culture of environmental responsibility, ensuring environmental compliance and promoting continual improvement across our operations.”
Promega announced the certification in its 2025 Corporate Responsibility Report, published today on the company’s website. In addition to sustainability metrics, the report captures how Promega supports scientists, employees and communities.
ISO 14001:2015 Certification
ISO 14001:2015 is an internationally recognized standard for environmental management systems. It provides a framework for organizations to identify, manage, monitor and improve their environmental performance. The standard helps businesses reduce waste, comply with regulations and minimize their environmental impact while enhancing sustainability efforts.
To achieve this certification, Promega demonstrated a strong environmental management system including adherence to environmental compliance requirements, mitigating environmental impact of our operations, and leadership commitment to sustainable best practices. A thorough review by independent auditors confirmed the company’s efforts in these areas.
Examples of Promega environmental initiatives include:
- Innovative product design that incorporates green chemistry and ambient shipping stability
- A global commitment to sourcing 100% renewable electricity by the end of 2025
- Employee-driven programs such as plastic film collection and recycling
- On-site composting to support the company garden using food and landscaping waste
2025 Corporate Responsibility Report
Since 2008, Promega has issued an annual Corporate Responsibility Report detailing its progress in sustainability, product impact, employee well-being and community engagement. Highlights of this year’s report include:
- Supporting Young Scientists: The Promega Rising Researchers Scientific Innovation Awards honor exceptional PhD students around the world with resources, mentorship and a visit to Promega Madison.
- Giving Back to Communities: The Promega in Action initiative gives Madison-based employees the opportunity to receive up to 40 hours of paid time off to volunteer for a nonprofit organization of their choice.
- Investing in Research and Innovation: Promega invested 13.8% of its revenue in R&D in 2024, propelling advancements in drug discovery, bioluminescence imaging and cellular metabolism.
The 2025 Corporate Responsibility Report contains additional information on how Promega considers the United Nations Sustainable Development Goals (SDGs) in its practices and actions.
Read the latest Corporate Responsibility Report here.
About Promega Corporation
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s portfolio of over 4,000 products supports a range of life science work across areas such as cell biology; DNA, RNA and protein analysis; drug development; human identification and molecular diagnostics. These tools and technologies have grown in their application over the last 45 years and are used today by scientists and technicians in labs for academic and government research, forensics, pharmaceuticals, clinical diagnostics and veterinary, agricultural and environmental testing. Promega is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. Learn more at promega.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250505641030/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting samarbejder med Mercurial Minds om at forbedre mulighederne inden for digital transformation4.7.2025 01:10:00 CEST | Pressemeddelelse
Andersen Consulting udvider sit udbud af teknologidrevne løsninger med tilføjelsen af samarbejdsfirmaet Mercurial Minds (M.M.), et konsulentfirma inden for digital transformation, AI og IT med base i Pakistan. M.M. blev grundlagt i 2013 og tilbyder en række tjenester, der er designet til at hjælpe organisationer med at udvikle sig og skalere, herunder i forbindelse med deres digitale transformationsstrategi, AI-tjenester, it-rådgivning og udvikling af robuste mobil- og webbrugeroplevelser. Firmaet leverer end-to-end-løsninger – udformning af datadrevne køreplaner, udvikling af intelligent automatisering og levering af sikre mobil- og weboplevelser, der kan skaleres – skræddersyet til virksomheder, der ønsker at forbedre sine forbindelsesmulighederne og opnå indsigter i realtid. M.M. betjener en bred vifte af brancher med fokus på finans, telekommunikation og andre dataintensive sektorer. "Dette samarbejde er en katalysator," siger Nabeel Saiyer, administrerende direktør for M.M. "Vores
Global Tourism Surging Ahead of Economic Growth, With Visits to Hit 30 Billion by 20344.7.2025 01:00:00 CEST | Press release
The World Economic Forum report, in collaboration with Kearney and the Ministry of Tourism Saudi Arabia, predicts a significant uptick in tourist trips across the globeThe tourism sector will contribute $16 trillion to global GDP (more than 11% of the global economy) by 2034, according to World Travel & Tourism Council estimates (WTTC)India and China will be responsible for more than 25% of all outbound travel by 2030 The World Economic Forum has today published a new report forecasting that the travel and tourism industry is projected to serve 30 billion tourist trips by 2034. Travel and Tourism at a Turning Point: Principles for Transformative Growth, produced in collaboration with Kearney and the Ministry of Tourism Saudi Arabia, reveals a projected $16 trillion contribution to global GDP by the same year—representing more than 11% of the total world economy, according to World Travel & Tourism Council estimates. The report also found that the sector is expanding 1.5 times faster th
The 2025-2026 World Branding Awards Animalis Edition Honouring Leading Pet and Animal Brands Globally3.7.2025 21:00:00 CEST | Press release
The 2025-2026 World Branding Awards Animalis Edition marked its fifth instalment, bringing together leading pet and animal brands from all around the world. These brands were celebrated for their outstanding achievements, earning recognition as National, Regional, and Global Winners. The awards ceremony, held at Vienna's prestigious Hofburg Palace, welcomed winners across diverse categories, including pet food, retail, wellness, pet exhibitions, and aquatic products. Mounia Berrada-Gouzi expertly hosted the evening, which culminated in a grand celebration of brand excellence. “The Animalis Edition of the World Branding Awards recognises brands that have achieved the highest distinction—genuine recognition in the hearts and minds of consumers. Tonight, we honour those whose names resonate globally, whose values inspire loyalty, and whose presence defines excellence in the pet and animal industry,” said Richard Rowles, Chairman of the World Branding Forum. Out of over 950 brands nominate
Venture Global Announces 20-Year Sales and Purchase Agreement with PETRONAS3.7.2025 14:59:00 CEST | Press release
Today, Venture Global, Inc. (NYSE: VG) announced the execution of a new 20-year Sales and Purchase Agreement (SPA) with PETRONAS LNG Ltd. (PLL), a subsidiary of the Malaysian state-owned oil and gas company, PETRONAS. Under the terms of the SPA, PETRONAS will purchase 1 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from Venture Global’s third facility, CP2 LNG, for 20 years. This builds upon Venture Global’s existing agreement with PETRONAS for 1 MTPA of LNG supply from Plaquemines LNG. PETRONAS, a world-class partner in the LNG industry, joins other CP2 LNG customers in Europe, Asia and the rest of the world in a strategically important project to global energy supply and security. To date, approximately 10.75 MTPA of the 14.4 MTPA nameplate capacity for CP2 Phase One has been sold. About Venture Global Venture Global is a long-term, low-cost provider of U.S. LNG sourced from resource rich North American natural gas basins. Venture Global’s business includes assets ac
Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year3.7.2025 14:05:00 CEST | Press release
In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost & Sullivan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250703950144/en/ Novotech Wins Global CRO Award Novotech is a globally recognized full-service clinical CRO and scientific advisory firm, trusted by biotech and small- to mid-sized pharmaceutical companies to advance their drug development programs at every phase. With a global footprint spanning Asia-Pacific, North America, and Europe, Novotech supports over 5,000 clinical trial sites and a distributed team of experts delivering seamless, end-to-end solutions across geographies. “Novotech is redefining biotech-focused clinical research through AI-driven innovation, global expansion, and a client-embedded partnership model. With a clear vision to be the CRO of choice for
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom